Journal of Experimental Therapeutics and Oncology
Impact Factor & Key Scientometrics

Journal of Experimental Therapeutics and Oncology
Overview

Impact Factor

NA

H Index

40

Impact Factor

0.2

I. Basic Journal Info

Country

United States
Journal ISSN: 13594117, 1533869X
Publisher: Old City Publishing
History: 1996, 2002-2020
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

Journal of Experimental Therapeutics and Oncology is devoted to the rapid publication of innovative preclinical investigations on therapeutic agents against cancer andpertinent findings of experimental and clinical oncology.In the journal you will find review articles original articles and short communications on all areas of cancer research including but not limited to preclinical experimentaltherapeutics anticancer drug development cancer biochemistry biotechnology carcinogenesis cancer cytogenetics clinical oncology cytokine biology epidemiologymolecular biology pathology pharmacology tumor cell biology and experimental oncology.

II. Science Citation Report (SCR)



Journal of Experimental Therapeutics and Oncology
SCR Impact Factor

Journal of Experimental Therapeutics and Oncology
SCR Journal Ranking

Journal of Experimental Therapeutics and Oncology
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

Journal of Experimental Therapeutics and Oncology
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Journal of Experimental Therapeutics and Oncology
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Journal of Experimental Therapeutics and Oncology
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Journal of Experimental Therapeutics and Oncology
Impact Factor History

2-year 3-year 4-year
  • 2023 Impact Factor
    0 0 0.176
  • 2022 Impact Factor
    0.2 0.133 0.509
  • 2021 Impact Factor
    0.2 0.691 0.6
  • 2020 Impact Factor
    0.46 0.587 0.76
  • 2019 Impact Factor
    0.554 0.711 0.718
  • 2018 Impact Factor
    0.6 0.766 0.689
  • 2017 Impact Factor
    0.442 0.538 0.566
  • 2016 Impact Factor
    0.675 0.902 1.078
  • 2015 Impact Factor
    0.833 1.64 1.617
  • 2014 Impact Factor
    1.622 NA NA
  • 2013 Impact Factor
    1.386 NA NA
  • 2012 Impact Factor
    1.146 NA NA
  • 2011 Impact Factor
    1.545 NA NA
  • 2010 Impact Factor
    2.152 NA NA
  • 2009 Impact Factor
    1.527 NA NA
  • 2008 Impact Factor
    1.979 NA NA
  • 2007 Impact Factor
    2.2 NA NA
  • 2006 Impact Factor
    1.846 NA NA
  • 2005 Impact Factor
    1.833 NA NA
  • 2004 Impact Factor
    1.609 NA NA
  • 2003 Impact Factor
    1.026 NA NA
  • 2002 Impact Factor
    0 NA NA
  • 2001 Impact Factor
    NA NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Journal of Experimental Therapeutics and Oncology
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

40

Journal of Experimental Therapeutics and Oncology
H-Index History